Skip to main content
Clinical Trials/NCT03467893
NCT03467893CompletedNot Applicable

Evaluation of Rebound Effect After Withdrawal of Proton Pump Inhibitor After 8 Weeks of Treatment in Geriatric Population

Fondation Hôpital Saint-Joseph1 site in 1 country30 target enrollmentStarted: June 10, 2017Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
30
Locations
1
Primary Endpoint
Number of antacids used

Study Overview

Brief Summary

Proton pump inhibitor are frequently used and are short term well tolerated ; but few studies show there are adverse event in long term prescription like fracture or pulmonary infection to Clostridum difficile. The fact is that multi medication in old patient increase the iatrogenic risk and decrease the medication compliance. The Proton pump inhibitor (PPI)are overused in this patient category.Several studies suggest the existence of a rebound effect when people were treated more than 8 weeks ; this effect seems to appear around 14 days after with hyperacidity symptoms.

But there are no studies about old patient. So in this context the aim of the study is to evaluate the prevalence of rebound effect occurence after the end of PPI 8 weeks treatment.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
65 Years to — (Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • patients hospitalized in post acute and rehabilitation service
  • more than 65 years old
  • PPI prescription more than 8 weeks

Exclusion Criteria

  • PPI prescription under 8 weeks
  • PPI prescription for digestive haemorragy

Outcomes

Primary Outcomes

Number of antacids used

Time Frame: Day 14 after end of treatment

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials